GlassScriptPhysician profile
Eugene H Kaskiw
NPI 1518956531
$2,361.08
in general payments reported to CMS, 2019-2025
34 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $339 · 2021: $388 · 2022: $285 · 2023: $194 · 2024: $306 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $243.73 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $220.28 | 2019-2025 | |
| Evofem Biosciences, INC. | $154.05 | 2021-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $138.11 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $132.45 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $117.13 | 2023-2025 | Myfembree |
| Daiichi Sankyo INC. | $109.94 | 2020-2022 | |
| Lupin INC. | $101.75 | 2019-2020 | |
| Organon LLC | $100.43 | 2022-2025 | Nexplanon |
| Medtronic, INC. | $98.63 | 2024 | Truclear |
| Astellas Pharma US INC | $96.25 | 2021-2025 | Veozah |
| Medtronic USA, INC. | $86.76 | 2019 | |
| Pfizer INC. | $86.30 | 2019-2023 | |
| Allergan, INC. | $81.07 | 2019 | |
| Exact Sciences Corporation | $78.00 | 2025 | Cologuard Collection Kit |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $76.63 | 2024-2025 | Aptima, Acessa Provu System |
| Amag Pharmaceuticals, INC. | $66.98 | 2019-2020 | |
| Therapeuticsmd, INC. | $42.21 | 2019-2022 | |
| Sage Therapeutics, LLC | $34.41 | 2024-2025 | Zurzuvae |
| Baxter Healthcare | $31.26 | 2025 | Floseal |
| Scynexis, INC. | $30.00 | 2022 | |
| Avion Pharmaceuticals | $27.81 | 2021 | |
| Millicent US INC | $27.54 | 2019-2020 | |
| Dysis Medical, INC. | $23.94 | 2021 | |
| Neuronetics, INC. | $21.19 | 2025 | Neurostar Tms Therapy System |
| Roche Diagnostics Corporation | $19.90 | 2021 | |
| Supernus Pharmaceuticals, INC. | $15.79 | 2025 | Qelbree |
| Myovant Sciences INC. | $15.69 | 2022 | |
| Coopersurgical, INC. | $15.00 | 2020 | |
| Vertical Pharmaceuticals, LLC | $14.93 | 2019 | |
| Shield Therapeutics INC | $14.57 | 2022 | |
| Channel Medsystems, INC. | $14.22 | 2023 | |
| Duchesnay USA Incorporated | $12.08 | 2019 | |
| Medicem INC. | $12.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Kaskiw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.